ArticleKidney international reports2026

A Multicenter Randomized Clinical Trial of Dapagliflozin in Patients Receiving Chronic Dialysis (The DARE-ESKD-2 Trial).

Joaquim Barreto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.